New
Vitiligo is a skin condition that affects up to 1.11% of the US population, causing loss of skin color and creating white patches on the skin. It can be especially upsetting when it affects the face, where it's more noticeable. Until recently, treatment options for vitiligo were limited to off-label drugs and therapies, but a new drug called Opzelura® has changed that.
Opzelura® is a cream that works by blocking certain proteins in the body that contribute to inflammation and the destruction of melanocytes, the cells responsible for skin pigmentation. By blocking these proteins, the drug helps to protect and preserve the melanocytes, allowing the skin to regain its natural color.
The European Commission has just approved Opzelura® for the treatment of non-segmental vitiligo in adults and adolescents with facial involvement. The EC decision follows the positive opinion received from the European Medicines Agency’s Committee earlier this year and is applicable to all 27 European Union Member States, Iceland, Norway and Liechtenstein.
Opzelura® was previously approved by the U.S. Food and Drug Administration (FDA) for the same indication, and now its approval in Europe is an important milestone in the effort to provide better care for individuals with vitiligo. This new treatment can be life-changing for those who have been struggling with this condition, helping them feel more confident and comfortable in their own skin.
INCYTE is the frontrunner among three dozen biotech companies developing vitiligo drugs, trailed by Pfizer with a drug candidate in Phase III clinical trials. Dig into exclusive report Vitiligo Drug Pipeline Analysis and Market Insights for more details.
FAQOther Questions
- Will it spread?
Vitiligo's progression and response to treatment can vary significantly among individuals, making it a particularly unpredictable skin condition. Based on the VALIANT study, her...
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
- Which therapy has minimal side-effects?
Dead Sea climatotherapy is a unique and highly effective treatment option for vitiligo, offering a top-tier safety profile and natural therapeutic benefits. Its combination of p...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.